Prognostic Factors of IIIAN2 Non-Small-Cell Lung Cancer after Complete Resection: A Systemic Review and Meta-analysis
Objective and Background. We designed this systemic review meta-analysis of all the reported scientific literature to conclude the prognostic factors of IIIAN2 non-small-cell lung cancer after complete surgical resection. Management of NSCLC IIIAN2 involved different strategies, such as complete res...
Gespeichert in:
Veröffentlicht in: | Computational and mathematical methods in medicine 2021-12, Vol.2021, p.1068090-8 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 8 |
---|---|
container_issue | |
container_start_page | 1068090 |
container_title | Computational and mathematical methods in medicine |
container_volume | 2021 |
creator | Wang, Youyu Wan, Yanhui Qian, Youhui |
description | Objective and Background. We designed this systemic review meta-analysis of all the reported scientific literature to conclude the prognostic factors of IIIAN2 non-small-cell lung cancer after complete surgical resection. Management of NSCLC IIIAN2 involved different strategies, such as complete resection, chemotherapy, radiotherapy, chemoradiotherapy, and induction therapy. Each management strategy has its associated prognostic factor to monitor for better patient prognosis, recovery, survival rate, and minimize the chances of recurrence. Methods. An extensive data search was conducted from all leading databases including PubMed, Google Scholar, Embase, and Cochrane. Fifteen studies were selected according to the PRISMA model of data selected to conduct this systemic review meta-analysis. Results. Total 4444 patients were evaluated among fifteen selected studies. A number of lymph nodes involved (n=3965), level of lymph nodes (n=3422), and complete tumor resection (n=3255) were the most reported prognostic factors. Conclusion. This study exhibits the overall significance of all prognostic factors of NSCLC IIIAN2 pathology for better patient management. However, other management strategies also play a significant contribution to achieving a better survival rate and less recurrence possibility. |
doi_str_mv | 10.1155/2021/1068090 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8687771</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2613294145</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-3875813457c7d1b8f5584b2f0b884e6c30665ded43832781a112f794900857aa3</originalsourceid><addsrcrecordid>eNp9kcFrFDEUhwdRbK3ePEuOgo7NyySTjIfCMlhdWKu0Ct5CNvNmG5lJ1iTTsv-9U3Zd9OLl5UE-vryXX1G8BPoOQIhzRhmcA60Vbeij4hQkV2UtQT0-9vTHSfEspZ-UCpACnhYnFW8qVXF5WkxfY9j4kLKz5NLYHGIioSfL5XJxxchV8OXNaIahbHEYyGryG9IabzES0-e5tmHcDpiRXGNCm13w78mC3OxSxnE2XuOdw3tifEc-Yzal8WbYJZeeF096MyR8cTjPiu-XH761n8rVl4_LdrEqLWc0l5WSQkHFhbSyg7XqhVB8zXq6VopjbSta16LDjs_LMKnAALBeNryhVAlpTHVWXOy922k9YmfR52gGvY1uNHGng3H63xvvbvUm3GlVKyklzILXB0EMvyZMWY8u2fkvjMcwJc1qqFjDgYsZfbtHbQwpReyPzwDVD0nph6T0IakZf_X3aEf4TzQz8GYP3DrfmXv3f91v8oKaUQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2613294145</pqid></control><display><type>article</type><title>Prognostic Factors of IIIAN2 Non-Small-Cell Lung Cancer after Complete Resection: A Systemic Review and Meta-analysis</title><source>MEDLINE</source><source>PubMed Central Open Access</source><source>Wiley-Blackwell Open Access Titles</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Wang, Youyu ; Wan, Yanhui ; Qian, Youhui</creator><contributor>Khalaf, Osamah Ibrahim</contributor><creatorcontrib>Wang, Youyu ; Wan, Yanhui ; Qian, Youhui ; Khalaf, Osamah Ibrahim</creatorcontrib><description>Objective and Background. We designed this systemic review meta-analysis of all the reported scientific literature to conclude the prognostic factors of IIIAN2 non-small-cell lung cancer after complete surgical resection. Management of NSCLC IIIAN2 involved different strategies, such as complete resection, chemotherapy, radiotherapy, chemoradiotherapy, and induction therapy. Each management strategy has its associated prognostic factor to monitor for better patient prognosis, recovery, survival rate, and minimize the chances of recurrence. Methods. An extensive data search was conducted from all leading databases including PubMed, Google Scholar, Embase, and Cochrane. Fifteen studies were selected according to the PRISMA model of data selected to conduct this systemic review meta-analysis. Results. Total 4444 patients were evaluated among fifteen selected studies. A number of lymph nodes involved (n=3965), level of lymph nodes (n=3422), and complete tumor resection (n=3255) were the most reported prognostic factors. Conclusion. This study exhibits the overall significance of all prognostic factors of NSCLC IIIAN2 pathology for better patient management. However, other management strategies also play a significant contribution to achieving a better survival rate and less recurrence possibility.</description><identifier>ISSN: 1748-670X</identifier><identifier>EISSN: 1748-6718</identifier><identifier>DOI: 10.1155/2021/1068090</identifier><identifier>PMID: 34938347</identifier><language>eng</language><publisher>United States: Hindawi</publisher><subject>Carcinoma, Non-Small-Cell Lung - pathology ; Carcinoma, Non-Small-Cell Lung - secondary ; Carcinoma, Non-Small-Cell Lung - surgery ; Computational Biology ; Humans ; Lung Neoplasms - pathology ; Lung Neoplasms - surgery ; Lymphatic Metastasis - pathology ; Neoplasm Staging ; Prognosis ; Review</subject><ispartof>Computational and mathematical methods in medicine, 2021-12, Vol.2021, p.1068090-8</ispartof><rights>Copyright © 2021 Youyu Wang et al.</rights><rights>Copyright © 2021 Youyu Wang et al. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-3875813457c7d1b8f5584b2f0b884e6c30665ded43832781a112f794900857aa3</citedby><cites>FETCH-LOGICAL-c420t-3875813457c7d1b8f5584b2f0b884e6c30665ded43832781a112f794900857aa3</cites><orcidid>0000-0002-9303-9531</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687771/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687771/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34938347$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Khalaf, Osamah Ibrahim</contributor><creatorcontrib>Wang, Youyu</creatorcontrib><creatorcontrib>Wan, Yanhui</creatorcontrib><creatorcontrib>Qian, Youhui</creatorcontrib><title>Prognostic Factors of IIIAN2 Non-Small-Cell Lung Cancer after Complete Resection: A Systemic Review and Meta-analysis</title><title>Computational and mathematical methods in medicine</title><addtitle>Comput Math Methods Med</addtitle><description>Objective and Background. We designed this systemic review meta-analysis of all the reported scientific literature to conclude the prognostic factors of IIIAN2 non-small-cell lung cancer after complete surgical resection. Management of NSCLC IIIAN2 involved different strategies, such as complete resection, chemotherapy, radiotherapy, chemoradiotherapy, and induction therapy. Each management strategy has its associated prognostic factor to monitor for better patient prognosis, recovery, survival rate, and minimize the chances of recurrence. Methods. An extensive data search was conducted from all leading databases including PubMed, Google Scholar, Embase, and Cochrane. Fifteen studies were selected according to the PRISMA model of data selected to conduct this systemic review meta-analysis. Results. Total 4444 patients were evaluated among fifteen selected studies. A number of lymph nodes involved (n=3965), level of lymph nodes (n=3422), and complete tumor resection (n=3255) were the most reported prognostic factors. Conclusion. This study exhibits the overall significance of all prognostic factors of NSCLC IIIAN2 pathology for better patient management. However, other management strategies also play a significant contribution to achieving a better survival rate and less recurrence possibility.</description><subject>Carcinoma, Non-Small-Cell Lung - pathology</subject><subject>Carcinoma, Non-Small-Cell Lung - secondary</subject><subject>Carcinoma, Non-Small-Cell Lung - surgery</subject><subject>Computational Biology</subject><subject>Humans</subject><subject>Lung Neoplasms - pathology</subject><subject>Lung Neoplasms - surgery</subject><subject>Lymphatic Metastasis - pathology</subject><subject>Neoplasm Staging</subject><subject>Prognosis</subject><subject>Review</subject><issn>1748-670X</issn><issn>1748-6718</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>RHX</sourceid><sourceid>EIF</sourceid><recordid>eNp9kcFrFDEUhwdRbK3ePEuOgo7NyySTjIfCMlhdWKu0Ct5CNvNmG5lJ1iTTsv-9U3Zd9OLl5UE-vryXX1G8BPoOQIhzRhmcA60Vbeij4hQkV2UtQT0-9vTHSfEspZ-UCpACnhYnFW8qVXF5WkxfY9j4kLKz5NLYHGIioSfL5XJxxchV8OXNaIahbHEYyGryG9IabzES0-e5tmHcDpiRXGNCm13w78mC3OxSxnE2XuOdw3tifEc-Yzal8WbYJZeeF096MyR8cTjPiu-XH761n8rVl4_LdrEqLWc0l5WSQkHFhbSyg7XqhVB8zXq6VopjbSta16LDjs_LMKnAALBeNryhVAlpTHVWXOy922k9YmfR52gGvY1uNHGng3H63xvvbvUm3GlVKyklzILXB0EMvyZMWY8u2fkvjMcwJc1qqFjDgYsZfbtHbQwpReyPzwDVD0nph6T0IakZf_X3aEf4TzQz8GYP3DrfmXv3f91v8oKaUQ</recordid><startdate>20211213</startdate><enddate>20211213</enddate><creator>Wang, Youyu</creator><creator>Wan, Yanhui</creator><creator>Qian, Youhui</creator><general>Hindawi</general><scope>RHU</scope><scope>RHW</scope><scope>RHX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-9303-9531</orcidid></search><sort><creationdate>20211213</creationdate><title>Prognostic Factors of IIIAN2 Non-Small-Cell Lung Cancer after Complete Resection: A Systemic Review and Meta-analysis</title><author>Wang, Youyu ; Wan, Yanhui ; Qian, Youhui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-3875813457c7d1b8f5584b2f0b884e6c30665ded43832781a112f794900857aa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Carcinoma, Non-Small-Cell Lung - pathology</topic><topic>Carcinoma, Non-Small-Cell Lung - secondary</topic><topic>Carcinoma, Non-Small-Cell Lung - surgery</topic><topic>Computational Biology</topic><topic>Humans</topic><topic>Lung Neoplasms - pathology</topic><topic>Lung Neoplasms - surgery</topic><topic>Lymphatic Metastasis - pathology</topic><topic>Neoplasm Staging</topic><topic>Prognosis</topic><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Youyu</creatorcontrib><creatorcontrib>Wan, Yanhui</creatorcontrib><creatorcontrib>Qian, Youhui</creatorcontrib><collection>Hindawi Publishing Complete</collection><collection>Hindawi Publishing Subscription Journals</collection><collection>Hindawi Publishing Open Access Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Computational and mathematical methods in medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Youyu</au><au>Wan, Yanhui</au><au>Qian, Youhui</au><au>Khalaf, Osamah Ibrahim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic Factors of IIIAN2 Non-Small-Cell Lung Cancer after Complete Resection: A Systemic Review and Meta-analysis</atitle><jtitle>Computational and mathematical methods in medicine</jtitle><addtitle>Comput Math Methods Med</addtitle><date>2021-12-13</date><risdate>2021</risdate><volume>2021</volume><spage>1068090</spage><epage>8</epage><pages>1068090-8</pages><issn>1748-670X</issn><eissn>1748-6718</eissn><abstract>Objective and Background. We designed this systemic review meta-analysis of all the reported scientific literature to conclude the prognostic factors of IIIAN2 non-small-cell lung cancer after complete surgical resection. Management of NSCLC IIIAN2 involved different strategies, such as complete resection, chemotherapy, radiotherapy, chemoradiotherapy, and induction therapy. Each management strategy has its associated prognostic factor to monitor for better patient prognosis, recovery, survival rate, and minimize the chances of recurrence. Methods. An extensive data search was conducted from all leading databases including PubMed, Google Scholar, Embase, and Cochrane. Fifteen studies were selected according to the PRISMA model of data selected to conduct this systemic review meta-analysis. Results. Total 4444 patients were evaluated among fifteen selected studies. A number of lymph nodes involved (n=3965), level of lymph nodes (n=3422), and complete tumor resection (n=3255) were the most reported prognostic factors. Conclusion. This study exhibits the overall significance of all prognostic factors of NSCLC IIIAN2 pathology for better patient management. However, other management strategies also play a significant contribution to achieving a better survival rate and less recurrence possibility.</abstract><cop>United States</cop><pub>Hindawi</pub><pmid>34938347</pmid><doi>10.1155/2021/1068090</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-9303-9531</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1748-670X |
ispartof | Computational and mathematical methods in medicine, 2021-12, Vol.2021, p.1068090-8 |
issn | 1748-670X 1748-6718 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8687771 |
source | MEDLINE; PubMed Central Open Access; Wiley-Blackwell Open Access Titles; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection |
subjects | Carcinoma, Non-Small-Cell Lung - pathology Carcinoma, Non-Small-Cell Lung - secondary Carcinoma, Non-Small-Cell Lung - surgery Computational Biology Humans Lung Neoplasms - pathology Lung Neoplasms - surgery Lymphatic Metastasis - pathology Neoplasm Staging Prognosis Review |
title | Prognostic Factors of IIIAN2 Non-Small-Cell Lung Cancer after Complete Resection: A Systemic Review and Meta-analysis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T07%3A46%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20Factors%20of%20IIIAN2%20Non-Small-Cell%20Lung%20Cancer%20after%20Complete%20Resection:%20A%20Systemic%20Review%20and%20Meta-analysis&rft.jtitle=Computational%20and%20mathematical%20methods%20in%20medicine&rft.au=Wang,%20Youyu&rft.date=2021-12-13&rft.volume=2021&rft.spage=1068090&rft.epage=8&rft.pages=1068090-8&rft.issn=1748-670X&rft.eissn=1748-6718&rft_id=info:doi/10.1155/2021/1068090&rft_dat=%3Cproquest_pubme%3E2613294145%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2613294145&rft_id=info:pmid/34938347&rfr_iscdi=true |